Where is Biomapas located?

Biomapas is headquartered in Kaunas, Lithuania.

How many employees does Biomapas have?

As of Sep 30, 2026, the latest employee count at Biomapas is 297.

What is the annual revenue of Biomapas?

Annual revenue of Biomapas is less than €1M as on Dec 31, 2024

Where does Biomapas rank among its competitors?

Biomapas ranks 5th amongst 214 active competitors, of which 5 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was PharmAla Biotech, which secured $1.09M in Dec, 2024.

Who are the top competitors of Biomapas?

Biomapas' top competitors include Vasta Global, CATALIS and PharmAla Biotech. Among them, PharmAla Biotech secured the most recent funding round in December, 2024.

Biomapas - 2026 Company Profile, Team, Funding, Competitors & Financials

Biomapas is an acquired company based in Kaunas (Lithuania), founded in 2001 by Audrius Sveikata. It operates as a Manufacturer of clinical research for medical devices. The company has 214 active competitors, including 5 funded and 17 that have exited. Its top competitors include companies like Vasta Global, CATALIS and PharmAla Biotech.

Company Details

Website: biomapas.com
Social

Key Metrics

Founded Year

2001

Location

Kaunas, Lithuania

Stage

Acquired

Investors

Carbyne Equity Partners

Ranked

5^th among 214 active competitors

Annual Revenue

€0 - €1M as on Dec 31, 2024

Employee Count

297 as on Sep 30, 2026

Investment & Acquisitions

Pinnaxis

Similar Companies

Vasta Global & 255 more

Exit Details

Acquired by Carbyne Equity Partners (Oct 17, 2024)

View Biomapas' full profile

Biomapas is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOMAPAS ZAGREB D.O.O. CIN: 4535322681 , Croatia, Active	Jul 17, 2022	€0 - €1M (As on Dec 31, 2024)	-

Biomapas got acquired by Carbyne Equity Partners on Oct 17, 2024.

Click here to take a look at Biomapas's acquisition in detail

Biomapas has not raised any funding rounds yet. Biomapas has 1 institutional investor.

View details of Biomapas's funding rounds and investors

The founders of Biomapas is Audrius Sveikata.

Here are the details of Biomapas' key team members:

Audrius Sveikata: Chairman and founder of Biomapas.

View details of Biomapas's Founder profiles and Board Members

Biomapas' employee count trend

Biomapas has 297 employees as of Sep 26. Here is Biomapas's employee count trend over the years:

Uncover Biomapas' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biomapas include Vasta Global, CATALIS and PharmAla Biotech. Here is the list of Top 10 competitors of Biomapas, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vasta Global 2010, Mumbai (India), Acquired	Offers clinical research consulting	-	-	57/100
2nd	CATALIS 2017, Montreal (Canada), Seed	Provider of consulting services for clinical drug development	$1.18M	AbbVie, Takeda & 6 others	47/100
3rd	PharmAla Biotech 2021, Toronto (Canada), Public	Provider of biomanufacturing, regulatory, and financial services	-	-	43/100
4th	S-Cubed 2007, Copenhagen (Denmark), Acquired	Clinical development consultancy services in areas such as biometrics, CDISC, and regulatory affairs	-	-	42/100
5th	Biomapas 2001, Kaunas (Lithuania), Acquired	Manufacturer of clinical research for medical devices	-	Carbyne Equity Partners	44/100
6th	Synterex 2016, Dedham (United States), Acquired	Provider of clinical development consulting services	-	-	40/100
7th	Blue Matter Consulting 2012, San Francisco (United States), Late Stage	Provider of consulting services focused for clinical drug development	-	Baird Capital	38/100
8th	Cerveau Technologies 2015, Boston (United States), Acquired	Innovating PET imaging agents for Alzheimer's disease research and diagnostics	-	-	36/100
9th	Orchestra Life Sciences 2021, Chesterfield (United States), Unfunded	Provider of technical consultancy for cancer and rare disease therapies	-	-	36/100
10th	MCRA 2004, New York City (United States), Funding Raised	Provider of regulatory, quality assurance and market access services to biopharma sector	-	Caltius Capital Management, Viscogliosi Brothers	35/100